Blaise Bratter

Blaise Bratter is the Chief Contributor to CannabisIntel. Being involved in the Australian cannabis industry since legalisation in 2016, he is now Operations Manager for ASX listed company MGC Pharmaceuticals.

Featured

THC Global gets a makeover

November 2, 2020

232

THC Gobal Group (ASX: THC) has released their strategy plan,...

Featured Research

AusCann launches research support programme

October 28, 2020

197

AusCann (ASX: AC8) has announced a research support programme for...

Featured Research

Zelira brings Hope to patients

October 27, 2020

199

Zelira (ASX: ZLD) brings two new targeted medicinal cannabis medications...

Featured

MGC Pharma drop-ships medicinal cannabis to Brazil

October 13, 2020

210

MGC Pharma (ASX: MXC) has made history, becoming the first...

Featured

Lifespot Health receives cash injection

October 2, 2020

270

Lifespot Health (ASX: LSH) has received a cash injection of...

Featured

Data reinforces logic showing positive treatment of CINV

September 30, 2020

Clinical trial results from a Phase II trial published in...

Featured

MGC Pharma advances Covid-19 trial

September 28, 2020

MGC Pharmaceuticals (ASX:MXC) continues to advance its clinical research on...

Featured

IHL achieves approval for Obstructive Sleep Apnoea trial

September 28, 2020

Incannex Healthcare (ASX:IHL) has received Human Research Ethics Committee (HREC)...

Featured Research

The Difference Between CBD Oil And Hemp Oil

August 11, 2020

107

If you haven't lived under a rock, you probably know...

Featured

Althea granted Hemp Cultivation Licence

June 6, 2019

1.07K

Althea (ASX: AGH) has been granted a Hemp Cultivation...

1 2 3 … 9

Page 1 of 9